Using patient test information routinely gathered by general practitioners, a computer system known as MILTON analyzes the data to find patterns and highly confidently predicts a disease diagnosis years later.
The artificial intelligence technology was created by the massive pharmaceutical company AstraZeneca, which claimed it will hasten the creation of more precise and potent medications.
However, it also makes the data openly accessible to other researchers, who may use it to create diagnostic tools that enable early therapy to halt the progression of diseases.
